Infusion solution

Active Pharmaceutical Ingredient:

Pharmacotherapeutic group:
Antithrombotic agents, Platelet aggregation inhibitors excl. heparin

Treatment of idiopathic or hereditary pulmonary arterial hypertension (PAH) to improve resilience and alleviate disease symptoms in patients with New York Heart Association (NYHA) functional class III.

Trisuva is used in adults (18 years of age and older).

Package size:
One 10 ml vial available in 3 concentrations:

  • 1 mg/ml
  • 2.5 mg/ml
  • 5 mg/ml
  • 10 mg/ml